Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pingxiao
- Development stage
- Unknown
- Lead developer
- Buchang Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Pingxiao is a traditional Chinese medicine (TCM) formula, most commonly administered as the Pingxiao capsule (PXC), used as an adjuvant therapy for various malignancies including breast, lung, and gastrointestinal cancers. It is composed of eight primary ingredients: *Curcuma phaeocaulis*, *Strychnos nux-vomica*, *Prunus persica*, *Alum*, *Nitrum*, *Resina Draconis*, *Aurantii Fructus*, and *Cinnabaris*. Pingxiao is characterized by its ability to induce apoptosis in cancer cells, inhibit tumor growth and metastasis, and modulate the immune response. In clinical practice, it is frequently combined with conventional chemotherapy or radiotherapy to enhance therapeutic efficacy and reduce treatment-induced toxicities, such as neutropenia. It is approved by the National Medical Products Administration (NMPA) in China.
- Brand names
- Pingxiao
- Other names
- Pingxiao capsulePXCPing Xiao
02
Targets
Beyond the preview
Go deeper on Pingxiao.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pingxiao.